3DUCHARME A,SWEDBERG K, PFEFFER M A, et al.prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure : assessment of Reduc- tion in Mortality and morbidity (CHARM)program [J].Am Heart J, 2006,151 : 985-991.
4Hailer H, ho S, Izzo JL Jr, et al.olmesartan for the delay or prevention of Mieroalbuminuria in type 2 diabetes [J].N Engl J Meal,2011,364 (10) :907-917.